Rx Drug Ads Should Not Characterize Probability Of Risk As Insignificant, FDA Emphasizes

Quantifying benefits and risks
FDA guidance advises drug manufacturers how to present quantitative efficacy and risk information in direct-to-consumer promotions • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from Compliance